DK2293687T3 - Funktionel fodersammensætning - Google Patents

Funktionel fodersammensætning Download PDF

Info

Publication number
DK2293687T3
DK2293687T3 DK09735856.8T DK09735856T DK2293687T3 DK 2293687 T3 DK2293687 T3 DK 2293687T3 DK 09735856 T DK09735856 T DK 09735856T DK 2293687 T3 DK2293687 T3 DK 2293687T3
Authority
DK
Denmark
Prior art keywords
fish
peptidoglycan
infection
composition
nucleotides
Prior art date
Application number
DK09735856.8T
Other languages
English (en)
Inventor
Vecino José Luis González
Simon Wadsworth
Original Assignee
Ewos Innovation As
Chemoforma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ewos Innovation As, Chemoforma Ltd filed Critical Ewos Innovation As
Application granted granted Critical
Publication of DK2293687T3 publication Critical patent/DK2293687T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (16)

1. Fiskefodersammensætning omfattende konventionelle foderingredienser, kendetegnet ved, at fodersammensætningen omfatter peptidoglykan og nukleoti-der, hvori peptidoglykan er i området 0,001-0,01 vægt-%, mere foretrukket 0,001-0,005 vægt-% og mest foretrukket 0,005 vægt-%.
2. Fodersammensætning ifølge krav 1, kendetegnet ved, at nukleotiderne er i området 0,05-1 vægt-%, fortrinsvis 0,1-0,5 vægt-% og mest foretrukket 0,2 vægt-%.
3. Fodersammensætning ifølge krav 1, kendetegnet ved, at vægtforholdet af nukleotider til peptidoglykan er mere end 4, mere foretrukket mere end 20, og mere foretrukket mere end 40, og mængden af peptidoglykan er i område 0,001-0,01% af fodersammensætningens vægt.
4. Fodersammensætning ifølge krav 1, hvori mængden af nukleotider er omkring 0,2% og mængden af peptidoglykan er omkring 0,005% af den samlede vægt af fodersammensætningen.
5. Fodersammensætning omfattende konventionelle foderingredienser, nukleotider og peptidoglykan til anvendelse ved forebyggelse og/eller behandling af infektionssygdomme i fisk og/eller til reduktion af symptomer på en infektionssygdom, hvori peptidoglykan er i området 0,001-0,01%
6. Fodersammensætning ifølge krav 5, hvori peptidoglykan er i området 0,001-0,005 vægt-% og fortrinsvis 0,005 vægt-%.
7. Fodersammensætning ifølge krav 5, hvori sammensætningen gives fisken i periode forud for udsættelse for en infektion, under infektionen, eller efter at fisken er blevet inficeret.
8. Fodersammensætning ifølge krav 5, hvori vægtforholdet af nukleotider til peptidoglykan er mere end 4, mere foretrukket mere end 20, og mere foretrukket mere end 40.
9. Fodersammensætning ifølge ethvert af krav 5-8 som en funktionel fodersammensætning til at hindre eller reducere symptomerne relateret til en infektionssygdom i en fisk.
10. Fodersammensætning ifølge ethvert af krav 5-9 til at øge overlevelse og/eller vækst i fisk udsat for en infektion.
11. Fodersymptomerne ifølge ethvert af krav 5-10, hvor infektionen er forårsaget af bakterier som Piscirikettsia salmonis, Moritella viscosa, Francisella sp, Mouth Rot, streptokokinfektioner, Vibrio infektioner; pancreassygdom, NSAV, gællebetændelse (GI), hjerte- og skeletmuskelinflammation (FISMI), smitsom salmoni-deanæmi (ISA) virus, Saprolegniosis og fiskelusangreb.
12. Fodersammensætning ifølge ethvert af krav 5 til 11, hvori fisken er en laksefisk, fortrinsvis atlanterhavslaks.
13. Fodersammensætning ifølge krav 5 til effektiv restitution påfølgende en infektion og/eller antibiotisk behandling på grund af en infektion og/eller for at reducere risikoen for reinfektion.
14. Sammensætning ifølge ethvert af krav 1-4 til anvendelse ved fodring af fisk, som er modtagelige for en infektion, hvori sammensætningen gives fisken i perioden forud for udsættelse for en infektion, hvori sammensætningen tilføres i en periode på 1-12 uger forud for infektionen.
15. Sammensætning ifølge krav 14, hvori sammensætningen tilføres i en periode på 2-6 uger forud for infektion, og mest foretrukket 4 uger forud for infektion.
16. Sammensætning ifølge krav 14, hvori fisken er en laksefisk, fortrinsvis atlanterhavslaks.
DK09735856.8T 2008-04-24 2009-04-24 Funktionel fodersammensætning DK2293687T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20081977A NO339169B1 (no) 2008-04-24 2008-04-24 Funksjonelt fiskefôr omfattende peptidoglykan og nukleotider
PCT/NO2009/000156 WO2009131467A1 (en) 2008-04-24 2009-04-24 Functional feed composition

Publications (1)

Publication Number Publication Date
DK2293687T3 true DK2293687T3 (da) 2016-01-18

Family

ID=40829504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09735856.8T DK2293687T3 (da) 2008-04-24 2009-04-24 Funktionel fodersammensætning

Country Status (11)

Country Link
US (1) US20110152177A1 (da)
EP (1) EP2293687B1 (da)
JP (2) JP2011518559A (da)
AU (1) AU2009238758B2 (da)
CA (1) CA2721746C (da)
CL (1) CL2009000987A1 (da)
DK (1) DK2293687T3 (da)
ES (1) ES2560517T3 (da)
NO (2) NO339169B1 (da)
NZ (1) NZ589483A (da)
WO (1) WO2009131467A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
CA2989391C (en) 2014-06-24 2023-03-14 John O'halloran Fish feed compositions containing a neonicotinoid for preventing and treating parasite infections
KR101755255B1 (ko) * 2015-04-30 2017-07-07 연세대학교 원주산학협력단 저대사 유도용 조성물, 저대사 유도방법 및 그 기술을 이용한 어류 운송방법
US11019836B2 (en) * 2015-08-03 2021-06-01 Savage River, Inc. Food products comprising cell wall material

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5422919B1 (da) * 1969-02-21 1979-08-09
JPH03164140A (ja) * 1989-11-21 1991-07-16 Sanyo Kokusaku Pulp Co Ltd 養魚用飼料組成物
JPH0655107B2 (ja) * 1991-03-13 1994-07-27 全国農業協同組合連合会 家畜，家禽，および魚介類用の抗仮性狂犬病ならびに抗病性飼料および飼料用添加物
JP3636207B2 (ja) * 1991-09-13 2005-04-06 エーザイ株式会社 免疫賦活・感染防御剤及びその製造方法
JP2547371B2 (ja) * 1992-03-03 1996-10-23 全国農業協同組合連合会 甲殻類、魚類用飼料、及び魚類用飼料の給餌方法
JPH06217712A (ja) * 1993-01-27 1994-08-09 Nippon Nousan Kogyo Kk 甲殻類用飼料
JP2756907B2 (ja) * 1993-12-28 1998-05-25 日本製紙株式会社 酵母エキス組成物及びその製造法並びにそれを含有する飼料
JPH10229831A (ja) * 1997-02-18 1998-09-02 Nippon Nousan Kogyo Kk 甲殻類の免疫賦活方法及び飼料添加剤
JP3942257B2 (ja) * 1998-01-06 2007-07-11 希能 澤口 機能性食品
JPH11255664A (ja) * 1998-03-10 1999-09-21 Ajinomoto Co Inc 経口投与用免疫増強剤
ATE440502T1 (de) * 1999-03-26 2009-09-15 Genichiro Soma Zusaetze fuer krustentier- bzw. fischfuttermittel sowie futtermittel
WO2001026481A1 (en) * 1999-10-13 2001-04-19 Ewos Limited Fish feed with increased nucleotide content
JP2001342141A (ja) * 2000-03-29 2001-12-11 Gotoo Yoshoku Kenkyusho:Kk 水棲動物・陸棲動物用薬剤及び飼料
JP2001342140A (ja) * 2000-03-29 2001-12-11 Gotoo Yoshoku Kenkyusho:Kk 魚類・甲殻類用薬剤及び飼料
JP2001340055A (ja) * 2000-03-31 2001-12-11 Nippon Paper Industries Co Ltd 家畜、家禽類給餌方法および給餌用人工乳組成物
JP2002173429A (ja) * 2000-09-29 2002-06-21 Nippon Paper Industries Co Ltd 魚類の免疫増強剤及び養魚用飼料
ATE447967T1 (de) * 2001-09-14 2009-11-15 Cytos Biotechnology Ag Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
NO315184B1 (no) * 2001-09-26 2003-07-28 Firmenich & Cie Anvendelse av en sammensetning basert på fiskemelke for fremstilling av etpreparat som öker immunoglobulinproduksjonen
JP2005515266A (ja) * 2001-11-16 2005-05-26 リージェント リサーチ エル．エル．ピー． 免疫刺激剤として活性である植物抽出物
JP4598519B2 (ja) * 2002-06-20 2010-12-15 サイトス バイオテクノロジー アーゲー アジュバントとして使用するためのパッケージ化されたウィルス様粒子：調製法及び使用法
JP2004121015A (ja) * 2002-09-30 2004-04-22 Kohjin Co Ltd 養殖魚の筋肉負担軽減化方法
WO2007095313A2 (en) * 2006-02-10 2007-08-23 The Roan Group, Inc. Microencapsulated nucleotide formulations for aquaculture and land animal feeds
WO2008051091A1 (en) * 2006-10-25 2008-05-02 Ewos Innovation As Fish feed and uses thereof

Also Published As

Publication number Publication date
US20110152177A1 (en) 2011-06-23
NO20081977L (no) 2009-10-26
NZ589483A (en) 2012-07-27
CA2721746A1 (en) 2009-10-29
AU2009238758B2 (en) 2014-01-30
CA2721746C (en) 2015-06-23
CL2009000987A1 (es) 2010-06-11
NO339169B1 (no) 2016-11-14
EP2293687A1 (en) 2011-03-16
JP2015027299A (ja) 2015-02-12
JP2011518559A (ja) 2011-06-30
ES2560517T3 (es) 2016-02-19
AU2009238758A1 (en) 2009-10-29
AU2009238758A2 (en) 2012-11-15
EP2293687B1 (en) 2015-10-28
WO2009131467A1 (en) 2009-10-29
NO20101539L (no) 2010-12-21

Similar Documents

Publication Publication Date Title
Hossain et al. Recent advances of nucleotide nutrition research in aquaculture: a review
Gatlin III Nutrition and fish health
Fuchs et al. The effect of supplementation with polysaccharides, nucleotides, acidifiers and Bacillus strains in fish meal and soy bean based diets on growth performance in juvenile turbot (Scophthalmus maximus)
Banu et al. Probiotic yeast enhanced growth performance and disease resistance in freshwater catfish gulsa tengra, Mystus cavasius
Bai et al. Additives in aquafeed: An overview
CA2576516C (fr) Additif alimentaire
US20220338506A1 (en) Method of increasing the productivity of a non-ruminant animal
US20220184159A1 (en) Method of boosting innate immunity
Montajami et al. Effect of symbiotic (Biomin imbo) on growth performance and survival rate of Texas cichlid (Herichthys cyanoguttatus) larvae
DK2293687T3 (da) Funktionel fodersammensætning
Jaramillo Jr et al. Comparison of purified and practical diets supplemented with or without β‐glucan and selenium on resistance of hybrid striped bass morone chrysops♀× M. saxatilis♂ to Streptococcus iniae infection
Li et al. Evaluation of levamisole as a feed additive for growth and health management of hybrid striped bass (Morone chrysops× Morone saxatilis)
Webster et al. Protein, amino acids, and ingredients
Gatlin et al. Nucleotides.
JPH05192088A (ja) 改善された養魚法
Divya et al. Effect of Enriched Artemia franciscana on Production, Survival, Growth and Biochemical Composition of the Freshwater Fish Catla catla (Hamilton, 1922)
Palíková et al. Preventive and prophylactic measures in intensive salmonid fish breeding–a review
Ng et al. Lactic acid enhanced the growth performance and resistance to Vibrio harveyi infection when added in the feeds of the giant freshwater prawn, Macrobrachium rosenbergii.
Jafaryan et al. The effects of Amax yeast fed to Persian sturgeon (Acipencer persicus) larvae via bioenrichment of Daphnia magna
Felix et al. Dietary mannan oligosaccharide enhances growth and survival of juvenile tiger shrimp Penaeus monodon against experimental challenge with Vibrio harveyi and white spot syndrome virus
Khodadadi et al. Dietary effect of celmanax® on growth factor, intestine histology and yersiniosis resistance in rainbow trout (Oncorhynchus mykiss)
Jintasataporn et al. The efficacy of a single cell protein (SCP) methanotroph (Methylococcus capsulatus, Bath) bacteria meal (FeedKind
Mohseni et al. Effect of brewer’s yeast (Saccharomyces cerevisiae) on growth, survival and immune response in Labeo rohita
Boloki et al. The effects of Amax yeast fed to Persian sturgeon (Acipencer persicus) larvae via bioenrichment of Daphnia magna.
Khodadadi et al. Effect of Lactobacillus plantarum on survival rate, biochemical and immunity parameters of Artemia hemolymph